Regent Pacific Group Limited (FRA:RPG)

Germany · Delayed Price · Currency is EUR

0.0870

-0.0010 (-1.14%)

Last updated: Oct 23, 2026, 5:00 PM CEST

Market Cap	26.75M +19.9%
Revenue (ttm)	4.73M +548.4%
Net Income	-1.71M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30
Open	0.0880
Previous Close	0.0880
Day's Range	0.0870 - 0.0880
52-Week Range	0.0590 - 0.1210
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholo... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1991

Employees 15

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol RPG

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD Financial Statements